Glutaminyl Cyclase, Diseases, and Development of Glutaminyl

Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease—Studies on Relation to Effective Target Occupancy

Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology

A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies

Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease - ScienceDirect

PDF) The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors

Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells

Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology

Some benzimidazole-based Glutaminyl Cyclase Inhibitors.

Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors

Discovery of potential scaffolds for glutaminyl cyclase inhibitors: virtual screening, synthesis, and evaluation - ScienceDirect

Therapeutic potential of glutaminyl cyclases: Current status and emerging trends - ScienceDirect

PDF) The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions